Exhibit 10.4
Execution Copy
THIS NOTE HAS
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “ACT”), OR APPLICABLE STATE SECURITIES
LAWS. IT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR
HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR EVIDENCE
REASONABLY SATISFACTORY TO THE BORROWER THAT SUCH REGISTRATION IS
NOT REQUIRED. THE SECURITIES ISSUED UPON SUCH CONVERSION
MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR
APPLICABLE STATE SECURITIES LAWS OR EVIDENCE REASONABLY
SATISFACTORY TO THE BORROWER THAT SUCH REGISTRATION IS NOT
REQUIRED.
SENIOR SECURED PROMISSORY
NOTE
FOR VALUE RECEIVED, Synvista Therapeutics, Inc.,
a Delaware corporation (the “ Borrower ”),
located at 221 West Grand Avenue, Montvale, NJ 07645, hereby
promises to pay to _______________________ (the “
Lender ”), located at
____________________________________________, or at such other
place as the Lender may from time to time reasonably designate, the
principal sum of ______________________ ($___________) (the “
Principal Amount ”) in lawful money of the United
States, in immediately available funds, ON DEMAND, on or after
____, 2012 (the “ Maturity Date ”).
1. Interest
shall accrue at a rate per annum equal to one and one-quarter
percent (1.25%) from the date hereof until maturity (whether by
demand on or after the Maturity Date or by
acceleration). Such interest shall be payable in cash at
maturity. In no event shall the rate of interest
hereunder exceed the maximum interest rate permitted by applicable
law.
2. This
Note is one of several notes (the “ Notes ”) in
the aggregate principal amount of up to $______ and of like tenor
issued by the Borrower to the Lender and others (together, the
“ Lenders ”) pursuant to the terms of that
certain Note Purchase Agreement, dated February __, 2009, as
amended (the “ Purchase Agreement
”). By acceptance of this Note, the Lender hereby
agrees that each of the Notes issued pursuant to the Purchase
Agreement shall rank equally and ratably without priority over one
another, and the Borrower agrees that, except as expressly provided
by the terms of the Notes, none of the Notes shall be paid, in
whole or in part, unless an equivalent, pro rata payment is made
with respect to all other Notes.
3. As
security for the payment, performance and observance of the
obligations set forth in this Note, the Borrower has granted a
security interest in its assets to the collateral agent named in,
and pursuant to, that certain Security Agreement, dated _______,
2009 (the “ Security Agreement ”) and that
certain Intellectual Property Security Agreement, dated _______,
2009 (the “ IP Security Agreement ” and
together with the Security Agreement, the “ Security
Agreements ”). Borrower hereby acknowledges
and agrees that the performance and observance of the obligations
set forth in this Note by the Borrower shall be deemed to be
“Obligations” for purposes of the Security
Agreements.
4. The
Borrower may prepay the principal balance of this Note plus accrued
but unpaid interest, without penalty, at any time prior to the
Maturity Date, provided that (a) at the date of prepayment there is
no Event of Default (as defined below) existing under this Note,
and (b) following the prepayment, the Company will have a minimum
cash balance of the greater of (i) one year of anticipated cash
expenditures for the Company, as determined by the Company’s
Board of Directors, or (ii) $7,500,000.
5. If
(a) the Borrower fails to make any payment under this Note; (b) the
Borrower breaches any representation, war
|